Medical Affairs - Visiting Scientist Fellowship FDE at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Internship, Entry Level & New GradExperience Level

Full TimeJob Type

NoVisa

Pharmaceutical, HealthcareIndustries

Requirements

PharmD, MD, relevant PhD and/or Master’s degree
Completion of required degree by June 2026 but not earlier than May 2023
Authorized to work in the United States on a full-time basis (Lilly will not provide support for or sponsor F-1 OPT, F-1 STEM OPT, J-1, H-1B, TN, O-1, E-3, H-1B1, or L-1 visas)

Responsibilities

Participate in a one-year postgraduate Visiting Scientist Fellowship program
Gain hands-on experience in medical, commercial, clinical development, project management, health outcomes, and regulatory aspects of the pharmaceutical industry
Be assigned to one department (e.g., Medical Affairs Strategic Capabilities, Medical Affairs Clinical Research Scientist-Immunology, Medical Affairs-Oncology, Medical Affairs-Neurology, Medical Affairs Clinical Research Scientist-Cardiometabolic Health, Medical Affairs Clinical Research Scientist-Cardiometabolic Health/NILEX, Patient Assistance Program, Medical Omnichannel Capabilities) while maintaining continuous contact with other functional areas
Engage in the drug development process through practical training for a career in the pharmaceutical industry

Skills

Key technologies and capabilities for this role

PharmDMDPhDClinical ResearchMedical AffairsImmunologyOncologyNeurologyCardiometabolic HealthDrug DevelopmentProject ManagementRegulatory AffairsHealth Outcomes

Questions & Answers

Common questions about this position

What are the basic qualifications for the Visiting Scientist Fellowship?

Candidates must hold a PharmD, MD, relevant PhD, or Master’s degree, complete the required degree by June 2026 but not earlier than May 2023, and be authorized to work in the United States on a full-time basis without sponsorship.

What is the duration and start date of the fellowship?

The Visiting Scientist Fellowship is a one-year postgraduate program with interviews beginning in October 2025 and an anticipated start date in June or July 2026.

What preferred skills are highlighted for applicants?

Strong interpersonal and communication skills, strong leadership, decision-making, and critical thinking skills, and a demonstrated ability to learn quickly are preferred.

What is the work arrangement or location for this fellowship?

This information is not specified in the job description.

What compensation or benefits are offered for the fellowship?

This information is not specified in the job description.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free